» Articles » PMID: 11131462

The Impact of the Hepatitis B Mass Immunisation Campaign on the Incidence and Risk Factors of Acute Hepatitis B in Italy

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2000 Dec 29
PMID 11131462
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: This study aimed to evaluate the impact of the campaign for hepatitis B mass immunisation of children and teenagers, introduced in 1991, on the incidence of and risk factors for hepatitis B in Italy.

Methods: Hepatitis B cases reported to the surveillance system for type-specific acute viral hepatitis (SEIEVA) during the period 1987-1997 were used to estimate incidence. To assess the association between potential risk factors and hepatitis B cases, hepatitis A cases generated by the same surveillance system were used as controls.

Results: During the period 1987-1997, 8275 acute hepatitis B cases were reported to SEIEVA. Hepatitis B incidence declined from 10.4/100,000 in 1987 to 2.9/100,000 in 1997. The fall was more evident before than after the introduction of compulsory vaccination against hepatitis B. The results of multivariate analysis showed that during the years 1995-1997, blood transfusion, intravenous drug use, surgical intervention, dental therapy, other parenteral exposures, multiple sexual partners, and being in the household of a chronic HBsAg carrier were all exposures independently associated with hepatitis B.

Conclusions: The strong association linking acute hepatitis B with iatrogenic exposures, which are more common in adults, suggests that the present immunisation strategy should be combined with the implementation of non-immunologic preventive measures.

Citing Articles

Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country.

Stroffolini T, Morisco F, Ferrigno L, Pontillo G, Iantosca G, Cossiga V Viruses. 2022; 14(2).

PMID: 35215839 PMC: 8875306. DOI: 10.3390/v14020245.


Future Healthcare Workers and Hepatitis B Vaccination: A New Generation.

Trevisan A, Mason P, Nicolli A, Maso S, Fonzo M, Scarpa B Int J Environ Res Public Health. 2021; 18(15).

PMID: 34360071 PMC: 8345783. DOI: 10.3390/ijerph18157783.


Hepatocellular carcinoma: old friends and new tricks.

Kim E, Viatour P Exp Mol Med. 2020; 52(12):1898-1907.

PMID: 33268834 PMC: 8080814. DOI: 10.1038/s12276-020-00527-1.


A Study on Hepatitis B Viral Seromarkers and Associated Risk Factors among the Patients Suffering from Acute and Chronic Hepatitis B Infection.

Prabina P, Jayanthi S, Krishna Murthy C, Kumar S, Banu A, Sakunthala S Int J Appl Basic Med Res. 2019; 9(4):206-211.

PMID: 31681544 PMC: 6822324. DOI: 10.4103/ijabmr.IJABMR_263_18.


Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors.

Stefanati A, Bolognesi N, Sandri F, Dini G, Massa E, Montecucco A J Prev Med Hyg. 2019; 60(3):E184-E190.

PMID: 31650052 PMC: 6797890. DOI: 10.15167/2421-4248/jpmh2019.60.3.1315.